 high titer cytopath viru plasma patient symptomat primari infect background primari infect human immunodefici viru acut self-limit viral syndrom relat viral replic immun respons host clinic ill initi phase infect quantit molecular biolog analysi infecti blood plasma patient symptomat primari infect sexual partner method eight-week period primari infect dilut plasma peripheral-blood mononuclear cell pbmc level antigen antibodi enzyme-link immunosorb assay immunoblot replication-compet provirus result six day onset symptom high titer infecti tissue-culture-infect dose millilit plasma viral antigen plasma patient titer day declin increas level antivir antibodi resolut symptom sequenti isol viru plasma pbmc period primari infect viru molecular provir clone cytopath normal-donor pbmc cell mark reduct titer viru plasma conclus primari symptomat infect high titer cytopath replication-compet viral strain infect potenti infect effect control replic primari infect activ import mechan immun defens examin relat develop antivir therapi vaccin